Video wird geladen...

Video konnte nicht geladen werden

Zur Startseite

🚨LANDMARK STUDY: Intranasal Nano-Ivermectin Shrinks Brain Tumors by 70% — With ZERO Toxicity Ivermectin nanocapsules DESTROY glioblastoma in animal models at doses LOWER than standard human doses. These findings align with ivermectin’s 14 distinct anti-cancer mechanisms.

NicHulscher's profile picture

Nicolas Hulscher, MPH

261,113 subscribers

164,580 Aufrufe • vor 10 Monaten •via X (Twitter)

Gesundheit & WellnessWissenschaft & TechnologieNachrichten & Politik
LIVE

Anya Rossi• Live Now

Private livecam show

0 Kommentare

Keine Kommentare verfügbar

Kommentare vom Original-Post werden hier angezeigt

Ähnliche Videos

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.
0:58

Nano-ivermectin shrinks glioblastoma brain tumors by 70% — with ZERO toxicity. A recent study found intranasal nano-ivermectin suppresses brain cancer in animal models at doses LOWER than the human anti-parasitic dose. This aligns with ivermectin’s 14 anti-cancer mechanisms.

Nicolas Hulscher, MPH

56,827 Aufrufe • vor 6 Monaten

A recent study found that ivermectin shrinks the most lethal brain cancer in existence by 70% in just 10 days — with ZERO toxicity. They implanted animals with glioblastoma brain tumors and delivered nano-ivermectin intranasally — driving a dramatic collapse in tumor burden.
0:46

A recent study found that ivermectin shrinks the most lethal brain cancer in existence by 70% in just 10 days — with ZERO toxicity. They implanted animals with glioblastoma brain tumors and delivered nano-ivermectin intranasally — driving a dramatic collapse in tumor burden.

Nicolas Hulscher, MPH

30,591 Aufrufe • vor 5 Monaten

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH
0:37

“There’s literally over 100 studies showing IVERMECTIN has over 12 distinct anti-cancer mechanisms across 12 cancer types. Glioblastoma brain tumors — one of the most lethal cancers in existence — Ivermectin shrunk the glioblastomas 70% in 10 days.” ~Nicolas Hulscher, MPH

Valerie Anne Smith

30,754 Aufrufe • vor 4 Monaten

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage IV cancers (Makis et al) ✅ Strong safety profile in humans ✅ Disrupts tumor metabolism & growth pathways 💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi): ✅ Boost NK & T cells ✅ Block angiogenesis ✅ Trigger apoptosis ✅ ↓ cancer risk by 34% (meta-analysis) ✅ ↑ survival & QoL (39 clinical trials) It’s time for cancer therapies that HEAL the body—not destroy it.
1:21

🚨Multiple Studies Confirm Ivermectin, Fenbendazole, & Mushrooms Exhibit Potent Anti-Cancer Activity via 20+ Mechanisms 💠Ivermectin: ✅ Proven safe—even with chemo ✅ Widespread anecdotal reports of remission ✅ 14 distinct anticancer mechanisms (systematic review) ✅ Targets glioblastoma, leukemia, ovarian, cervical cancers & more 💠Fenbendazole: ✅ Linked to remission of Stage IV cancers (Makis et al) ✅ Strong safety profile in humans ✅ Disrupts tumor metabolism & growth pathways 💠Medicinal Mushrooms (Cordyceps, Turkey Tail, Reishi): ✅ Boost NK & T cells ✅ Block angiogenesis ✅ Trigger apoptosis ✅ ↓ cancer risk by 34% (meta-analysis) ✅ ↑ survival & QoL (39 clinical trials) It’s time for cancer therapies that HEAL the body—not destroy it.

Nicolas Hulscher, MPH

199,492 Aufrufe • vor 11 Monaten

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.
9:41

When I caught Covid, my friends rushed doses of Ivermectin to me — kicked Covid in 24 hours. Here’s a cancer surgeon revealing her discoveries about the impact of Ivermectin on CANCER… 9 min. must see: Also — Compelling Evidence for Ivermectin in Treating Covid: · Front Line COVID-19 Critical Care Alliance Review — This review, which summarized findings from 27 studies, concluded that ivermectin demonstrates a strong signal of therapeutic efficacy against COVID-19. This includes both prevention and treatment aspects. · Meta-Analysis on Ivermectin — A meta-analysis covering 96 studies and over 135,000 patients suggests that ivermectin has shown effectiveness in combating COVID-19. This analysis points towards ivermectin's role in reducing severity and improving health outcomes. · Antiviral Effect Study — A study aimed at assessing the antiviral effect of high-dose ivermectin found it to have an impact on viral load, suggesting its potential in reducing the severity of the disease by decreasing the viral replication. Evidence for Ivermectin in Treating Cancer as summarized by Dr. William Makis, Radiologist, Oncologist, Cancer Researcher. NEW ARTICLE: IVERMECTIN and Protocols for CANCER Ivermectin has a dozen anti-cancer mechanisms but they can be summarized into two main ones: 1. Inhibits cancer proliferation signaling pathways (Akt, mTOR, Wnt) 2. Inhibits Cancer Stem Cells IVERMECTIN will act against regular CANCER as well as Pfizer and Moderna COVID-19 mRNA Vaccine Induced TURBO CANCER (which is highly resistant to chemo) Here are recent studies on IVERMECTIN use in certain types of cancer: BLADDER CANCER - (2024 Fan et al) - Ivermectin Inhibits Bladder Cancer Cell Growth and Induces Oxidative Stress and DNA Damage LUNG CANCER - (2024 Man-Yuan Li et al) - Ivermectin induces nonprotective autophagy by downregulating PAK1 and apoptosis in lung adenocarcinoma cells GLIOMA - (2024 Xing Hu et al) - Ivermectin as a potential therapeutic strategy for glioma MULTIPLE MYELOMA - (2024 Yang Song et al) - Gene signatures to therapeutics: Assessing the potential of ivermectin against t(4;14) multiple myeloma OVARIAN CANCER - (2023 Jawad et al) - Ivermectin augments the anti-cancer activity of pitavastatin in ovarian cancer cells PROSTATE CANCER - (2022 Lu et al) - Integrated analysis reveals FOXA1 and Ku70/Ku80 as targets of ivermectin in prostate cancer COLON CANCER - (2022, Alghamdi et al) - Efficacy of ivermectin against colon cancer induced by dimethylhydrazine in male wistar rats PANCREATIC CANCER - (2022 Lee et al) - Ivermectin and gemcitabine combination treatment induces apoptosis of pancreatic cancer cells via mitochondrial dysfunction MELANOMA - (2022 Zhang et al) - Drug repurposing of ivermectin abrogates neutrophil extracellular traps and prevents melanoma metastasis IVERMECTIN has proven anti-cancer activity against some 20 cancer types, although these are pre-clinical studies. We will never see clinical studies because Ivermectin is off patent and cheap. Merck, which used to have a patent on Ivermectin, has partnered with Moderna on mRNA Cancer Vaccines. IVERMECTIN is so safe, that in much of the civilized world, it is available over the counter, no prescription needed. Ivermectin is annually taken by close to 250 million people.

Bobby

160,046 Aufrufe • vor 1 Jahr

A Soviet Study Found Ivermectin Had Anti-Cancer Properties. The CIA Classified It. It Wasn't Declassified Until 2011. Soviet scientists discovered that anti-parasitics and tumors share similar mechanisms — and that these compounds showed anti-cancer activity in animals. The CIA buried the study during the Cold War. Decades of potential cancer research lost. Johns Hopkins now holds a patent on mebendazole as an anti-cancer agent. The science was never the problem. The suppression was. Join the Fight: Courtesy of The Absolute Truth The Absolute Truth with Emerald Robinson ✝️, Emerald Robinson Emerald Robinson ✝️ #MedicalFreedom
1:15

A Soviet Study Found Ivermectin Had Anti-Cancer Properties. The CIA Classified It. It Wasn't Declassified Until 2011. Soviet scientists discovered that anti-parasitics and tumors share similar mechanisms — and that these compounds showed anti-cancer activity in animals. The CIA buried the study during the Cold War. Decades of potential cancer research lost. Johns Hopkins now holds a patent on mebendazole as an anti-cancer agent. The science was never the problem. The suppression was. Join the Fight: Courtesy of The Absolute Truth The Absolute Truth with Emerald Robinson ✝️, Emerald Robinson Emerald Robinson ✝️ #MedicalFreedom

McCullough Foundation

39,910 Aufrufe • vor 4 Monaten

🚨Diagnosed with Cancer, Doctors told Pete Sulack he had a 1% survival chance & only 8 months left to live...now he is in FULL REMISSION. Did he use Chemo & Radiation? NO... Instead of surrendering to the standard protocol, he chose to heal with IVERMECTIN & MEBENDAZOLE. 📚 Here’s what the research shows: • Ivermectin crosses the blood-brain barrier, blocks angiogenesis, and modulates immune checkpoints • Mebendazole disrupts microtubule formation in glioblastoma and lung cancer models • Together, they’re being explored in terrain-based cancer models for apoptosis, metabolism, and more Pete used Ivermectin & Mebendazole in a protocol by Ilyes Baghli, stacked with fasting, targeted nutrition, detox, oxygen therapy and faith. And now? He's in full remission. 💡 This isn’t about miracle pills. It’s about rebuilding the terrain so your body can do what it was designed to do. Share your cancer story below & look for the protocol linked as the 1st reply...
1:04

🚨Diagnosed with Cancer, Doctors told Pete Sulack he had a 1% survival chance & only 8 months left to live...now he is in FULL REMISSION. Did he use Chemo & Radiation? NO... Instead of surrendering to the standard protocol, he chose to heal with IVERMECTIN & MEBENDAZOLE. 📚 Here’s what the research shows: • Ivermectin crosses the blood-brain barrier, blocks angiogenesis, and modulates immune checkpoints • Mebendazole disrupts microtubule formation in glioblastoma and lung cancer models • Together, they’re being explored in terrain-based cancer models for apoptosis, metabolism, and more Pete used Ivermectin & Mebendazole in a protocol by Ilyes Baghli, stacked with fasting, targeted nutrition, detox, oxygen therapy and faith. And now? He's in full remission. 💡 This isn’t about miracle pills. It’s about rebuilding the terrain so your body can do what it was designed to do. Share your cancer story below & look for the protocol linked as the 1st reply...

Valerie Anne Smith

256,723 Aufrufe • vor 7 Monaten

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds
5:47

🚨Dr. William Makis: Ivermectin Dosing for Cancer Explained In one of his recent talks, Dr. William Makis shared what he considers the most important dosing guide for using Ivermectin in cancer. According to Dr. Makis, the starting dose for most cancers is 1 mg per kilogram of body weight per day For example, a person weighing 60 kg would take 60 mg daily, that’s five 12 mg pills or roughly one teaspoon (6 ml) of liquid ivermectin. He mentioned that Ivermectin has shown positive effects in many types of cancer, including: - Breast cancer - Colon cancer - Lung cancer - Pancreatic cancer - Gastric cancer - Renal cell carcinoma - Leukemias He noted that there is very little research on lymphomas, but that doesn’t mean it won’t work, it simply hasn’t been studied much yet. Important points from Dr. Makis: 1) The anti-cancer effect of Ivermectin appears to be dose dependent. 2) Higher doses may offer better results in more aggressive cancers. 3) For very aggressive cancers (such as pancreatic, leukemia, or brain cancers), he suggests considering 2 mg/kg or even up to 2.5 mg/kg per day. Some patients have used these higher doses for many months with only temporary side effects (such as mild visual disturbances that usually resolve within a few days). Real-world examples include a prostate cancer patient whose PSA dropped from 89 to 11 on 45 mg daily, and a terminal gallbladder cancer case that resolved after 14 months on 2 mg/kg. Dr. Makis emphasizes that Ivermectin is a very safe drug with no reported long-term side effects at 1 mg/kg. He recommends starting at this dose and adjusting upwards depending on the individual case and cancer type. He also stresses that people can safely stay on Ivermectin for months as long as there is active disease. If you're researching Ivermectin for cancer protocols, many people are choosing GENIX MEDS for clean, pharmaceutical-grade Ivermectin with straightforward worldwide delivery. #Ivermectindosage #MakisMD #Genixmeds

GENIX MEDS

19,941 Aufrufe • vor 2 Monaten

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🚨🚨 Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. 💊 IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). 💊 MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Joe Tippens

25,626 Aufrufe • vor 2 Monaten

🚨Diagnosed with Cancer, Doctors told Pete Sulack he had a 1% survival chance & only 8 months left to live...now he is in FULL REMISSION. Did he use Chemo & Radiation? NO... Instead of surrendering to the standard protocol, he chose to heal with IVERMECTIN & MEBENDAZOLE. 📚 Here’s what the research shows: • Ivermectin crosses the blood-brain barrier, blocks angiogenesis, and modulates immune checkpoints • Mebendazole disrupts microtubule formation in glioblastoma and lung cancer models • Together, they’re being explored in terrain-based cancer models for apoptosis, metabolism, and more Pete used Ivermectin & Mebendazole in a protocol by Ilyes Baghli, stacked with fasting, targeted nutrition, detox, oxygen therapy and faith. And now? He's in full remission. 💡 This isn’t about miracle pills. It’s about rebuilding the terrain so your body can do what it was designed to do. Share and repost this message to increase awareness. It is essential for the public to be informed. Follow my page for further motivational and educational content.
1:14

🚨Diagnosed with Cancer, Doctors told Pete Sulack he had a 1% survival chance & only 8 months left to live...now he is in FULL REMISSION. Did he use Chemo & Radiation? NO... Instead of surrendering to the standard protocol, he chose to heal with IVERMECTIN & MEBENDAZOLE. 📚 Here’s what the research shows: • Ivermectin crosses the blood-brain barrier, blocks angiogenesis, and modulates immune checkpoints • Mebendazole disrupts microtubule formation in glioblastoma and lung cancer models • Together, they’re being explored in terrain-based cancer models for apoptosis, metabolism, and more Pete used Ivermectin & Mebendazole in a protocol by Ilyes Baghli, stacked with fasting, targeted nutrition, detox, oxygen therapy and faith. And now? He's in full remission. 💡 This isn’t about miracle pills. It’s about rebuilding the terrain so your body can do what it was designed to do. Share and repost this message to increase awareness. It is essential for the public to be informed. Follow my page for further motivational and educational content.

Joe Tippens

73,310 Aufrufe • vor 6 Monaten

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.
3:43

7 Compelling Reasons Why Ivermectin Is a ‘Powerful Drug’ for Fighting Cancer Ivermectin is often recognized–2nd to penicillin–for having the greatest impact on human health. Its discovery even won the Nobel Prize. It is safer than Tylenol and brought river blindness to the brink of extinction, but the propagandists told you it was a “dangerous horse dewormer.” Well, it now turns out that ivermectin is not only an effective treatment for COVID-19, but it could also be a “powerful drug” for fighting cancer. Here are 7 reasons why. 1. Multiple Anti-Cancer Effects: Ivermectin impacts at least nine well-defined cancer targets, according to Dr. Alfonso Dueñas-González, an oncologist and senior researcher. He states, "There are at least nine perfectly defined cancer targets affected by ivermectin." 2. Enhances Effects of Chemotherapy and Radiation: Ivermectin not only targets tumor stem cells and promotes cancer cell death but also "enhances the effects of chemo and radiation therapy." This broad impact on the immune system increases the offense against cancers, making it a versatile adjunct to conventional treatments. 3. Inhibits Cancer Cell Cycles: The drug prevents the formation of new cancer cells by inhibiting cancer cell cycles and inducing mitochondrial stress, which leads to the killing of cancer cells. This mechanism is crucial for stopping the proliferation of cancerous cells. 4. Prevents Formation of New Blood Vessels Near Cancer Cells: Ivermectin prevents cancer survival by inhibiting the formation of new blood vessels that transport energy and fuel to cancers. This action starves the cancer cells, hindering their growth and spread. 5. Synergizes with Immunotherapy: Dr. Peter P. Lee, chair of immuno-oncology at the City of Hope, found that ivermectin could synergize with immune checkpoint inhibitor anti-PD1, enhancing the body's immune response to fight cancer. "What we’re learning is that ivermectin is going to be a very powerful drug in the context of really carefully developed immunotherapy combinations," he said. 6. Targets Cancer Stem Cells: Ivermectin preferentially targets cancer stem cells, which are a driver of cancer tumors and relapses. By focusing on these cells, ivermectin attacks the root of cancer's resilience and ability to recur. 7. The Curious Case of Rick Alderson: Mr. Alderson, a retired sawmill worker, “was a dead man walking” and given 6 months to live after his terminal colon cancer had metastasized and spread to his liver, where it had formed 25 distinct tumors. After starting ivermectin, Rick Alderson's carcinoembryonic antigen (CEA) levels, which are markers for tumor activity, dropped significantly from 1,498 ng/mL to 13.9 ng/mL in a matter of months. Of the 25 tumors in Mr. Alderson's liver, only three remained after his treatment with ivermectin and chemotherapy, indicating a substantial reduction in tumor burden. Mr. Alderson lived for two more years beyond his initial six-month prognosis, which his wife attributes to the use of ivermectin alongside chemotherapy.

The Vigilant Fox 🦊

532,851 Aufrufe • vor 2 Jahren

"Ivermectin's Miraculous Results For Neurological Conditions Of Parkinson's & Alzheimer's." Dr William Makis Buried Research, Deleted From Google, Has Been Found, Proving Ivermectin Reverses Alzheimer's. Neurological Disease Improves In Only A Few Days On Ivermectin Therapy... Dementia affects more than 55 million people globally, with Alzheimer’s disease (AD) being the most prevalent subtype. These neurodegenerative disorders, including debilitating Parkinson's Disease, progressively impairs memory, cognition, daily functioning, muscle & body control. As interest grows in repositioning known compounds for neurodegenerative applications, ivermectin—a macrocyclic lactone with FDA-approved antiparasitic use—has surfaced as a candidate for neurological disease therapy. Deleted Research Study That Google Scrubbed... I Found It Last Week After Hours Of Research. Here Is A Paraphrased Summary In 'Non Scientific' Regular Language: 70 male Wistar rats were used in the research study. At baseline the rats had cognitive ability to do a task session at the rate of 2.8 minutes with 1.3 errors. Alzheimer's Disease (AD) was induced by injecting them with ALUMINUM CHLORIDE until their cognitive ability to do the same task session regressed to the slow rate of 6.5 minutes with 4.4 errors. These rats were then given IVERMECTIN for 4 consecutive weeks. The same task session improved drastically from 6.5 minutes back to only 3.6 minutes. And the rate of errors improved from 4.4 back to only 1.4 errors. Almost back to baseline in only 4 weeks at 3.6 minutes with 1.4 errors. Recent studies have explored its effects on neuroinflammation, neurotransmission & synaptic protection. Ivermectin’s Effects On Neurological Disease: 1. Anti-Inflammatory Effects: A 2023 study published in Inflammation demonstrated that ivermectin mitigates neuroinflammatory damage in encephalomyelitis. Ivermectin reduced inflammatory cytokines. 2. Stabilizes Neurotransmission: A 2019 study in PLOS Pathogens found that ivermectin restores balance in synaptic neuro pathways. 3. Cholinergic Transmission: A 2024 study published in Cell & Bioscience reported that ivermectin increased activity of striatal cholinergic interneurons, enhancing dopamine release via nicotinic receptor modulation. Conclusion: Ivermectin is emerging as more than an antiparasitic agent. Its anti-inflammatory, synaptic & cholinergic effects are beneficial in neurodegenerative disorders like Dementia, Alzheimer's & Parkinson's. Dosages suggested by Dr William Makis: Parkinson’s: Patients on high-dose ivermectin (60-72mg) saw dramatic improvements in movement & symptoms. - Multiple cases of symptom reversal—where tremors, stiffness & rigidity significantly improved. Alzheimer’s: Patients on low-dose ivermectin (12-24 mg for 4-5 days) brought back memories, recognition & cognitive function in patients. Why Isn’t This Everywhere? - A preclinical Alzheimer’s study proving ivermectin’s healing ability was SCRUBBED from Google. - Big Pharma doesn’t profit from a safe, cheap, Nobel Prize-winning drug that reverses neurodegeneration. This isn’t theoretical—it’s happening NOW in real patients. Decades of suffering could be reversed by a few pills. If you have a loved one with Parkinson’s or Alzheimer’s—TRY IT. The results could be LIFE-CHANGING. 👇Ivermectin Reverses Alzheimer's (Deleted Study)👇 👇Ivermectin For Autoimmune & Neurological Ills👇 👇Ivermectin Increases Choline & Dopamine👇 Speaker: Dr William Makis, Nuclear Medicine Physician & Cancer Researcher
3:57

"Ivermectin's Miraculous Results For Neurological Conditions Of Parkinson's & Alzheimer's." Dr William Makis Buried Research, Deleted From Google, Has Been Found, Proving Ivermectin Reverses Alzheimer's. Neurological Disease Improves In Only A Few Days On Ivermectin Therapy... Dementia affects more than 55 million people globally, with Alzheimer’s disease (AD) being the most prevalent subtype. These neurodegenerative disorders, including debilitating Parkinson's Disease, progressively impairs memory, cognition, daily functioning, muscle & body control. As interest grows in repositioning known compounds for neurodegenerative applications, ivermectin—a macrocyclic lactone with FDA-approved antiparasitic use—has surfaced as a candidate for neurological disease therapy. Deleted Research Study That Google Scrubbed... I Found It Last Week After Hours Of Research. Here Is A Paraphrased Summary In 'Non Scientific' Regular Language: 70 male Wistar rats were used in the research study. At baseline the rats had cognitive ability to do a task session at the rate of 2.8 minutes with 1.3 errors. Alzheimer's Disease (AD) was induced by injecting them with ALUMINUM CHLORIDE until their cognitive ability to do the same task session regressed to the slow rate of 6.5 minutes with 4.4 errors. These rats were then given IVERMECTIN for 4 consecutive weeks. The same task session improved drastically from 6.5 minutes back to only 3.6 minutes. And the rate of errors improved from 4.4 back to only 1.4 errors. Almost back to baseline in only 4 weeks at 3.6 minutes with 1.4 errors. Recent studies have explored its effects on neuroinflammation, neurotransmission & synaptic protection. Ivermectin’s Effects On Neurological Disease: 1. Anti-Inflammatory Effects: A 2023 study published in Inflammation demonstrated that ivermectin mitigates neuroinflammatory damage in encephalomyelitis. Ivermectin reduced inflammatory cytokines. 2. Stabilizes Neurotransmission: A 2019 study in PLOS Pathogens found that ivermectin restores balance in synaptic neuro pathways. 3. Cholinergic Transmission: A 2024 study published in Cell & Bioscience reported that ivermectin increased activity of striatal cholinergic interneurons, enhancing dopamine release via nicotinic receptor modulation. Conclusion: Ivermectin is emerging as more than an antiparasitic agent. Its anti-inflammatory, synaptic & cholinergic effects are beneficial in neurodegenerative disorders like Dementia, Alzheimer's & Parkinson's. Dosages suggested by Dr William Makis: Parkinson’s: Patients on high-dose ivermectin (60-72mg) saw dramatic improvements in movement & symptoms. - Multiple cases of symptom reversal—where tremors, stiffness & rigidity significantly improved. Alzheimer’s: Patients on low-dose ivermectin (12-24 mg for 4-5 days) brought back memories, recognition & cognitive function in patients. Why Isn’t This Everywhere? - A preclinical Alzheimer’s study proving ivermectin’s healing ability was SCRUBBED from Google. - Big Pharma doesn’t profit from a safe, cheap, Nobel Prize-winning drug that reverses neurodegeneration. This isn’t theoretical—it’s happening NOW in real patients. Decades of suffering could be reversed by a few pills. If you have a loved one with Parkinson’s or Alzheimer’s—TRY IT. The results could be LIFE-CHANGING. 👇Ivermectin Reverses Alzheimer's (Deleted Study)👇 👇Ivermectin For Autoimmune & Neurological Ills👇 👇Ivermectin Increases Choline & Dopamine👇 Speaker: Dr William Makis, Nuclear Medicine Physician & Cancer Researcher

Valerie Anne Smith

636,406 Aufrufe • vor 1 Jahr

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.
1:37

🔴Ivermectin and mebendazole attack cancer cells in many different ways. Chemotherapy usually attacks only one.... Cancer has to be attacked through multiple mechanisms simultaneously... Ivermectin and mebendazole together do exactly that: they block cell division, cut off glucose metabolism, target cancer stem cells, and much more... Dr. Peter McCullough. IVERMECTIN – 12 Known Anti-Cancer Actions: 1. Inhibits the WNT/β-catenin pathway: stops the proliferation of cancer cells. 2. Induces apoptosis: triggers programmed death of cancer cells. 3. Blocks importin α/β transporter proteins, preventing replication of cancer cells. 4. Inhibits the PAK1 enzyme: reduces inflammation and tumor progression. 5. Antiangiogenic: stops the formation of new blood vessels in tumors. 6. Immune system modulator: improves recognition of cancer cells. 7. Autophagy disruptor: interferes with cancer cells' survival strategies. 8. Targets glioblastoma stem cells: effective in brain cancers. 9. Inhibits mitochondrial respiration: cuts off energy supply to tumors. 10. Disrupts mTOR signaling, slowing cell growth. 11. Overcomes chemotherapy resistance: makes chemotherapy more effective. 12. Antiviral properties: potentially useful for virus-related cancers (like HPV). MEBENDAZOLE – 12 Known Anti-Cancer Action: 1. Microtubule destabilization: similar to fenbendazole 2. Inhibits angiogenesis and blocks the growth of new blood vessels. 3. Triggers apoptosis: causes the death of cancer cells. 4. Inhibits VEGF signaling: blocks blood supply signals to the tumor. 5. Crosses the blood-brain barrier: useful for brain cancers. 6. Activates caspase-3/7 enzymes, involved in programmed cell death. 7. Reduces expression of the MYC oncogene, slowing tumor growth. 8. Inhibits the Bcl-2 protein, reducing cancer cell survival. 9. Anti-metastatic: reduces cancer spread. 10. Alters mitochondrial function: impairs energy production in tumor cells. 11. Improves chemotherapy sensitivity: helps standard treatments work better. 12. Low toxicity + long safety history: used in humans for decades. Follow me for more Bombshell.

Commentary | Global Ivermectin Research Hub

25,225 Aufrufe • vor 2 Monaten

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds
5:47

🚨 DR. WILLIAM MAKIS SAYS THIS IS THE MOST IMPORTANT IVERMECTIN DOSING GRAPH HE'S CREATED. Not a new chemotherapy drug. Not a breakthrough immunotherapy. Not a billion-dollar cancer treatment. Just one simple dosing strategy. According to Dr. William Makis, this is the dosing framework he believes everyone researching repurposed medicines for cancer should understand first. And it all starts with one number. 📌 1 mg/kg/day. Before explaining why, here's the dosing framework Dr. Makis discusses. 📊 The Four Ivermectin Dosing Ranges 🟢 Low Dose: ≤0.5 mg/kg/day Used for cancers in remission, strong family history, genetic predisposition, prophylaxis, and lower-dose protocols discussed in published case reports. 🟡 Medium Dose: 1.0 mg/kg/day Dr. Makis' recommended starting dose for most cancers. 🔵 High Dose: 2.0 mg/kg/day Discussed for very aggressive cancers, including leukaemia, pancreatic cancer, and some brain cancers. 🔴 Very High Dose: ≥2.5 mg/kg/day Discussed in selected reported cases involving extensive metastatic disease or extremely poor prognosis, where temporary visual side effects have also been reported. Now here's why Dr. Makis believes 1 mg/kg/day deserves the most attention. After reviewing laboratory research, published studies, and numerous case reports, he says this is the starting dose he recommends for most cancers. According to Dr. Makis, research has investigated Ivermectin across a surprisingly wide range of cancers, including: • Breast cancer • Colon cancer • Lung cancer • Pancreatic cancer • Kidney (renal cell) cancer • Gastric cancer • Leukemia One exception stood out. Lymphoma. Dr. Makis says he has found very little published research involving Ivermectin and lymphoma. That doesn't mean it doesn't work. It simply means the evidence is currently limited. ❓What does 1 mg/kg/day actually look like? For someone weighing 60 kg (132 lbs)... That's approximately 60 mg of Ivermectin every day. Equivalent to: 💊 Five 12 mg tablets OR 💧 About 6 mL of liquid Ivermectin, roughly one teaspoon. According to Dr. Makis, that's where he recommends starting for many cancers. Can lower doses still have an effect? ✅ He believes they can. Dr. Makis discusses a published ovarian cancer case reported by Dr. Tess Lawrie. The dosing chart lists the patient as receiving 12 mg of Ivermectin per day. During his discussion, Dr. Makis explains that this was approximately 0.2 mg/kg/day, placing it within the chart's Low Dose (≤0.5 mg/kg/day) range. 📉 According to the case report, the patient's CA125 tumor marker reportedly fell from 288 to 22 after two months. That case is one reason Dr. Makis believes Ivermectin may have anticancer activity even at lower doses. However... He also believes the available evidence suggests the effect is dose dependent. In other words... Higher doses may produce greater effects, although more clinical research is needed. What about the most aggressive cancers? • Pancreatic cancer • Leukemia • Brain cancer For cancers like these, Dr. Makis discusses doses around 2 mg/kg/day in selected situations. He notes that Ivermectin crosses the blood-brain barrier, although not very efficiently, which is one reason he says higher doses may be considered for some brain cancers. He also discusses a case reported by Dr. Allan Landrito. According to Dr. Makis, a physician with terminal gallbladder cancer reportedly took 2 mg/kg/day for 14 months. He says her cancer eventually disappeared. She experienced temporary visual side effects that resolved after a few days. ❓How high have reported doses gone? According to Dr. Makis, he has seen reported doses as high as 2.5 mg/kg/day. He references patients treated by Dr. Shankara Chetty who reportedly used those doses without long-term side effects, although some experienced temporary visual disturbances that later resolved. One point Dr. Makis returns to repeatedly... Long-term use. He references the Castro study involving children with leukemia who reportedly received Ivermectin for six months without long-term side effects. He also discusses anecdotal reports of adults taking it daily for more than a year without long-term toxicity. So why aren't there larger cancer trials? Dr. Makis believes one of the biggest obstacles is economics. Because Ivermectin is an off-patent generic medicine, he argues there is little financial incentive to fund large clinical trials. Whether future research ultimately confirms or challenges these ideas remains to be seen. But Dr. Makis' message is remarkably simple. One graph. One dosing strategy. One starting point. 📌 1 mg/kg/day. Because the conversation isn't just about Ivermectin anymore. It's about whether repurposed drugs deserve the same level of scientific investigation as newer therapies. 🗨️ Do you think inexpensive repurposed medicines like Ivermectin deserve larger, well-designed clinical trials for cancer? 🔖 Save this post so you'll always have Dr. Makis' dosing framework handy, and repost it to help others discover the ongoing research into repurposed medicines. 💊 Looking for pharmaceutical grade Ivermectin, Fenbendazole, or Mebendazole? Choose RXMEDS.STORE. Trusted by thousands of customers worldwide. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #CancerCare #MedicalResearch #PancreaticCancer #MakisMD #RxMeds

RXMEDS.STORE

353,990 Aufrufe • vor 1 Monat

#BREAKING Ivermectin as a Potential Hazard? While ivermectin is widely used in both veterinary and human medicine, misuse or overdose can result in serious toxicity—especially in genetically sensitive individuals or animals. Toxic effects may affect the nervous system, digestive tract, and cardiovascular functions. General Risks Include: Neurological Effects: Seizures, confusion, tremors, disorientation, ataxia (loss of coordination), and even coma. Gastrointestinal Symptoms: Vomiting, diarrhea, and appetite loss. Respiratory Depression: Difficulty breathing, collapse, and—in extreme cases—death. Animal Studies (Rodents and Others): At very high doses, far beyond typical therapeutic levels, ivermectin has shown potential reproductive risks: Lower fertility Poor sperm quality Disrupted ovarian function Embryotoxicity and pregnancy complications These effects were dose-dependent and not commonly seen at standard treatment levels. Common Causes of Adverse Effects: Incorrect or excessive dosing Use of livestock formulations in pets or humans Administering canine heartworm medications to sensitive species, breeds, or individuals Bottom Line: Ivermectin can be effective when used correctly. But inappropriate use—especially high-dose or cross-species dosing—poses real and potentially severe risks to both animals and humans.
2:52

#BREAKING Ivermectin as a Potential Hazard? While ivermectin is widely used in both veterinary and human medicine, misuse or overdose can result in serious toxicity—especially in genetically sensitive individuals or animals. Toxic effects may affect the nervous system, digestive tract, and cardiovascular functions. General Risks Include: Neurological Effects: Seizures, confusion, tremors, disorientation, ataxia (loss of coordination), and even coma. Gastrointestinal Symptoms: Vomiting, diarrhea, and appetite loss. Respiratory Depression: Difficulty breathing, collapse, and—in extreme cases—death. Animal Studies (Rodents and Others): At very high doses, far beyond typical therapeutic levels, ivermectin has shown potential reproductive risks: Lower fertility Poor sperm quality Disrupted ovarian function Embryotoxicity and pregnancy complications These effects were dose-dependent and not commonly seen at standard treatment levels. Common Causes of Adverse Effects: Incorrect or excessive dosing Use of livestock formulations in pets or humans Administering canine heartworm medications to sensitive species, breeds, or individuals Bottom Line: Ivermectin can be effective when used correctly. But inappropriate use—especially high-dose or cross-species dosing—poses real and potentially severe risks to both animals and humans.

Jack Straw

27,055 Aufrufe • vor 1 Jahr

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD
4:38

🚨 "Researchers Have Identified Around a Dozen Anti Cancer Mechanisms for Ivermectin." Dr. Makis Explains Why It Keeps Getting Studied. Most people know Ivermectin as an antiparasitic medicine. According to Dr. William Makis, researchers have now identified around a dozen different mechanisms through which Ivermectin has shown anticancer activity in laboratory and preclinical studies. That's why scientists continue investigating it decades after its introduction. One story Dr. Makis shared especially stood out. A woman being treated for breast cancer contacted him because her tumor was shrinking. But that wasn't what excited her the most. According to Dr. Makis, she told him that uterine fibroids she'd lived with for nearly 20 years had disappeared during the same period. He says researchers have investigated some of the same cellular pathways involved in the growth of certain benign tumors, including fibroids. So what exactly are researchers studying? 📌 Cancer Stem Cells Dr. Makis says laboratory research suggests Ivermectin may interfere with cancer stem cells, which are believed to play an important role in tumor growth, spread, and recurrence. 📌 Chemotherapy Resistance He also says researchers have investigated whether Ivermectin may help reverse molecular mechanisms associated with chemotherapy resistance in cancer cells. 📌 Tumor Growth Pathways According to Dr. Makis, studies suggest Ivermectin may influence signaling pathways involved in tumor proliferation, making it an ongoing area of scientific investigation. He also discussed laboratory research in mice showing that Ivermectin affected rapidly proliferating lymphoma cells while leaving normal spleen cells largely unaffected. According to Dr. Makis, researchers still don't fully understand how this selectivity occurs at the molecular level. One molecule. Around a dozen proposed anticancer mechanisms. That's one reason Ivermectin continues to attract scientific attention. Another fact many people overlook... 🏆 Ivermectin was awarded the 2015 Nobel Prize in Physiology or Medicine for its impact on treating parasitic diseases. Since then, researchers around the world have continued exploring whether the same molecule may have applications beyond parasitic infections. Whether future clinical trials ultimately confirm, refine, or challenge today's findings remains to be seen. But the scientific interest hasn't disappeared. In many ways, it's still growing. One medicine. Around a dozen proposed anticancer mechanisms. Decades of research. And scientists are still asking new questions. 🔁 Share this so others can learn why Ivermectin continues to be one of the most discussed repurposed medicines in cancer research. 💊 Whether you're researching Ivermectin, Fenbendazole, or Mebendazole, find pharmaceutical-grade options you can trust at RXMEDS.STORE. #Ivermectin #CancerResearch #RepurposedDrugs #Oncology #MedicalResearch #Cancer #NobelPrize #MakisMD

RXMEDS.STORE

18,224 Aufrufe • vor 29 Tagen

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells
2:06

🚨 Why Ivermectin Shows So Much Promise Against Cancer (But Almost No Human Trials) Ivermectin doesn’t just have one or two effects on cancer; it has over a dozen different mechanisms of action. Here are some of the key ones: - Kills cancer stem cells (the cells chemotherapy often misses) - Reverses multidrug resistance, making cancer cells more sensitive to chemotherapy again - Acts as a radiosensitizer, helping radiation work better - Inhibits angiogenesis (stops tumors from forming new blood vessels) - Blocks matrix metalloproteinases, which helps prevent cancer from spreading and metastasizing Despite hundreds of preclinical studies showing these effects, there are almost no large human trials. Only small case reports exist (for example, some leukemia patients showing remission). Why? Because Ivermectin has been off-patent since the 1990s. It’s a cheap, generic drug. When there’s no money to be made, tragically, large-scale research rarely happens, especially in oncology. This is the same story with many other repurposed drugs. Promising lab results exist, but without financial incentive, human trials rarely move forward. That’s why so many patients are now doing their own research into these options. If you're exploring Ivermectin or Fenbendazole protocols, many people are choosing clean, pharmaceutical-grade versions from PharmacyinUSA. Save this for reference. #Ivermectin #CancerResearch #RepurposedDrugs #Fenbendazole #CancerStemCells

PharmacyinUSA

12,063 Aufrufe • vor 1 Monat

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD
6:19

IVERMECTIN and LACTOFERRIN TESTIMONIAL - Oscar Nacu (Philippines, Aug.2022) IVERMECTIN and LACTOFERRIN Synergy Both compounds exhibit anticancer properties through overlapping pathways, such as inducing apoptosis (programmed cell death), modulating immune responses, and disrupting cancer cell metabolism and proliferation Lactoferrin can enhance Ivermectin’s effects by amplifying immune activation and oxidative stress, which may make cancer cells more vulnerable to IVM’s metabolic disruptions and apoptotic induction 1. Enhanced Apoptosis and Cell Death Pathways Individual Mechanisms: Lactoferrin induces apoptosis in cancer cells by damaging the cytoskeleton, activating caspases (e.g., caspase-3), upregulating pro-apoptotic proteins like BAX/BAK, and causing cell cycle arrest (e.g., G1/S or G2/M phases). It also reduces cell migration and invasion by reversing epithelial-mesenchymal transition (EMT), downregulating proteins like vimentin, SNAIL, and TWIST. Ivermectin promotes apoptosis via mitochondrial dysfunction, increasing reactive oxygen species (ROS), elevating the Bax/Bcl-2 ratio, and activating caspases 9/3. It also inhibits proliferation through cell cycle arrest and targets cancer stem cells. How They Work Together: Lactoferrin’s ability to induce oxidative stress and DNA damage complements Ivermectin’s ROS elevation and mitochondrial inhibition. This dual assault on cellular energy and redox balance could lower the threshold for apoptosis, making cancer cells more susceptible to Ivermectin’s effects 2. Immune Modulation and Tumor Microenvironment Remodeling Individual Mechanisms: Lactoferrin stimulates the adaptive immune response, reshapes the tumor microenvironment by downregulating pro-inflammatory cytokines (e.g., IL-6), and inhibits cancer progression through immunostimulatory effects. It also protects against iron disorders, depriving iron-dependent cancer cells while modulating immunity. Ivermectin has immunomodulatory properties, converting “cold” tumors (immune-deserted) to “hot” ones (immune-infiltrated) by inducing immunogenic cell death (ICD), releasing ATP and HMGB1, depleting immunosuppressive cells (e.g., MDSCs and Tregs), and enhancing CD8+ T-cell infiltration. How They Work Together: Lactoferrin’s cytokine downregulation and immune stimulation could amplify Ivermectin’s ICD and T-cell recruitment, creating a more hostile environment for cancer cells. For example, Ivermectin’s ability to boost Teff/Treg ratios pairs well with Lactoferrin’s anti-inflammatory effects, potentially enhancing overall antitumor immunity. 3. Disruption of Cancer Cell Metabolism and Proliferation Individual Mechanisms: Lactoferrin inhibits oncogenic pathways like PI3K/AKT/mTOR and Wnt, reducing proliferation and angiogenesis (e.g., downregulating VEGFR2). Ivermectin interferes with metabolic pathways, downregulating TCA cycle enzymes (e.g., IDH2, DLST), inhibiting glycolysis/oxidative phosphorylation, and limiting glutamine-derived intermediates for biosynthesis. How They Work Together: Lactoferrin’s iron sequestration starves cancer cells of essential metals for metabolic enzymes, synergizing with Ivermectin’s TCA cycle disruption to exacerbate energy shortages and biosynthetic limitations. This is particularly relevant in “glutamine-addicted” cancers like ovarian or prostate, where combined metabolic stress promotes apoptosis. (Podcast: Dr.Allan Landrito, Dr.Mahin Khatami, Dr.Shankara Chetty" === I have the world's largest Ivermectin Cancer Clientele, 7900 strong! Joseph A. Ladapo, MD, PhD

Dr. William Makis MD

48,226 Aufrufe • vor 7 Monaten

"Most Impressive Of All Is Ivermectin Cream Will Completely Clear Skin Cancers...Basal Cell Carcinoma, Squamous Cell Carcinoma & Melanoma Will Heal & Fall Off." "Topical Ivermectin Will Heal Any Inflammatory Or Autoimmune Skin Condition Including Rosacea, Cystic Acne & Eczema." Dr. William Makis, radiologist, oncologist & cancer researcher. Ivermectin has anti-inflammatory, anti-viral, anti-bacterial & anti-tumor properties. Ivermectin has amazing topical applications...skin cancers disappearing after a few weeks of applying it twice a day...the skin cancer literally falls off. People with the worst type of cystic acne are completely clearing that lifelong painful debilitating condition. Ivermectin is a pretty fascinating veritable wonder drug. It’s primarily known as a broad-spectrum antiparasitic agent with multiple mechanisms of action. The story of its discovery, in the 1960s when Satoshi Ōmura stumbled upon a unique soil bacteria. This bacteria produced something called avermectin, & ivermectin is essentially a synthetic derivative of this component. Ivermectin Cream Treats These Dermatology Conditions: Rosacea Eczema Psoriasis Facial Mites Scabies Demodex Skin Mites Perioral Dermatitis Hookworms Lice Basal Cell Carcinoma Squamous Cell Carcinoma Melanoma Moles Warts Skin Tags Ringworm Candida Athlete's Foot Purchasing Topical Ivermectin Cream In 1 of 2 Ways: #1: Doctor Rx Prescription for 1% cream...pharmacy filled & purchased after doctor visit or diagnosis. #2: Over The Counter private purchase of 1.87% cream at any veterinary, pet or farm supply store for immediate use. Most creams & pastes sell for under $10 & are ready for immediate use without a doctor visit, copay or pharmacy visit. Dosage For Over The Counter Private Purchase: Twice per day, massage in a pea sized/pencil eraser sized amount onto affected area or lesion. 👇Ivermectin Clears Skin Cancers👇 👇Ivermectin Paste For Melanoma👇 👇Nobel Prize For Ivermectin Human Use👇 👇Ivermectin Use In Dermatology👇 Speaker: Dr William Makis Video: @Jasiel1117 Jasiel Created To Heal
1:30

"Most Impressive Of All Is Ivermectin Cream Will Completely Clear Skin Cancers...Basal Cell Carcinoma, Squamous Cell Carcinoma & Melanoma Will Heal & Fall Off." "Topical Ivermectin Will Heal Any Inflammatory Or Autoimmune Skin Condition Including Rosacea, Cystic Acne & Eczema." Dr. William Makis, radiologist, oncologist & cancer researcher. Ivermectin has anti-inflammatory, anti-viral, anti-bacterial & anti-tumor properties. Ivermectin has amazing topical applications...skin cancers disappearing after a few weeks of applying it twice a day...the skin cancer literally falls off. People with the worst type of cystic acne are completely clearing that lifelong painful debilitating condition. Ivermectin is a pretty fascinating veritable wonder drug. It’s primarily known as a broad-spectrum antiparasitic agent with multiple mechanisms of action. The story of its discovery, in the 1960s when Satoshi Ōmura stumbled upon a unique soil bacteria. This bacteria produced something called avermectin, & ivermectin is essentially a synthetic derivative of this component. Ivermectin Cream Treats These Dermatology Conditions: Rosacea Eczema Psoriasis Facial Mites Scabies Demodex Skin Mites Perioral Dermatitis Hookworms Lice Basal Cell Carcinoma Squamous Cell Carcinoma Melanoma Moles Warts Skin Tags Ringworm Candida Athlete's Foot Purchasing Topical Ivermectin Cream In 1 of 2 Ways: #1: Doctor Rx Prescription for 1% cream...pharmacy filled & purchased after doctor visit or diagnosis. #2: Over The Counter private purchase of 1.87% cream at any veterinary, pet or farm supply store for immediate use. Most creams & pastes sell for under $10 & are ready for immediate use without a doctor visit, copay or pharmacy visit. Dosage For Over The Counter Private Purchase: Twice per day, massage in a pea sized/pencil eraser sized amount onto affected area or lesion. 👇Ivermectin Clears Skin Cancers👇 👇Ivermectin Paste For Melanoma👇 👇Nobel Prize For Ivermectin Human Use👇 👇Ivermectin Use In Dermatology👇 Speaker: Dr William Makis Video: @Jasiel1117 Jasiel Created To Heal

Valerie Anne Smith

1,695,288 Aufrufe • vor 1 Jahr